Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since ...

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

A group of pro-cannabis entities scheduled to present in the forthcoming cannabis rescheduling hearing have filed a new ...

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

The agency is accused of improperly opposing the rescheduling proposal, conspiring with prohibitionist groups and stacking ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

I've been bullish on NewLake Capital Partners since June 2024, but headwinds have impacted its stock price. Read why I remain ...

Pro-cannabis groups allege with new evidence that the agency has actively shown an "unalterably closed mind" toward marijuana ...